In all treated patients, at the End of Treatment (
Post# of 148175
(Total Views: 615)
Posted On: 08/11/2020 9:42:39 AM
Quote:I have stumbled over this several times.
In all treated patients, at the End of Treatment (or Day 14), patients in the leronlimab group were more than twice as likely to experience a beneficial improvement in scores compared to patients in the placebo group (50% vs 20%; p=0.0223).
Similar, statistically significant, results were observed at Day 3 and Day 14 in the analysis of per protocol population (p<0.03 and p<0.02, respectively).
Should that sentence read:
Similar, statistically significant, results were observed at Day 3 and Day 7 in the analysis of per protocol population (p<0.03 and p<0.02, respectively).
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼